© 2024 Omaada - A global social and professionals networking platform Portuguese
Atualizações Recentes
- Enhancing Patient Outcomes through Clinical Communication and CollaborationAccording to a new report by MarketsandMarkets™ - Clinical Communication & Collaboration Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $4.8 billion by 2029, growing at a CAGR of 13.2% from 2024 to 2029. The growth in the clinical communication and collaboration market is driven by high prevalence of chronic diseases, rising...0 Comentários 0 CompartilhamentosFaça Login para curtir, compartilhar e comentar!
- Insights into the Sleep Apnea Oral Appliances Market: Emerging Technologies and Competitive StrategiesAccording to a new report by MarketsandMarkets - Sleep Apnea Oral Appliances Market in terms of revenue was estimated to be worth $0.4 billion in 2023 and is poised to reach $0.9 billion by 2028, growing at a CAGR of 15.2% from 2023 to 2028. The growth of this market is majorly driven by the high risk of growing awarrness and diagnosis of sleep apnea among patients and healthcare...0 Comentários 0 Compartilhamentos
- Advancements in Endoscopy Equipment Market Technology: Shaping the Market LandscapeAccording to a new report by MarketsandMarkets™. - Endoscopy Equipment Market in terms of revenue was estimated to be worth $32.3 billion in 2024 and is poised to reach $46.2 billion by 2029, growing at a CAGR of 7.4% from 2024 to 2029. The growth in this market is primarily driven by factors such as increasing prevalence of gastrointestinal diseases, rising demand for minimally invasive...0 Comentários 0 Compartilhamentos
- The Rise of Companion Diagnostics: Transforming Drug Development and Patient CareAccording to a new report by MarketsandMarkets™ - Companion Diagnostics Market in terms of revenue was estimated to be worth $7.5 billion in 2024 and is poised to reach $13.6 billion by 2029, growing at a CAGR of 12.6% from 2024 to 2029. The global companion diagnostics market is poised for significant growth in the near future, driven by the increasing incidence of cancers...0 Comentários 0 Compartilhamentos
- Insightful Trends: Exploring the Optometry Equipment MarketAccording to a new report by MarketsandMarkets™ - Optometry Equipment Market in terms of revenue was estimated to be worth $4.5 billion in 2024 and is poised to reach $6.1 billion by 2029, growing at a CAGR of 6.4% from 2024 to 2029. The principal drivers propelling the expansion of this market are the growing prevalence of eye illnesses, advancements in ophthalmic device...0 Comentários 0 Compartilhamentos
- Regulatory Frameworks and Compliance in the Cartilage Repair MarketCartilage Repair Market / Cartilage Regeneration market in terms of revenue was estimated to be worth $1.3 Billion in 2023 and is poised to reach $2.8 Billion by 2028, growing at a CAGR of 17.2% from 2023 to 2028 according to a latest report published by MarketsandMarkets™. Growth in the Cartilage Repair/Cartilage Regeneration market is mainly driven by the Increasing incidence of...0 Comentários 0 Compartilhamentos
- Forecasting Glycated Albumin Assay Market: Growth Trends and Market PotentialGlycated Albumin Assay Market in terms of revenue was estimated to be worth $0.2 billion in 2023 and is poised to reach $0.3 billion by 2028, growing at a CAGR of 8.9% from 2023 to 2028 according to a new report by MarketsandMarkets™. Government assistance is stimulating the market. Players in the glycated albumin assay market have significant potential in developing nations like...0 Comentários 0 Compartilhamentos
- Expanding Horizons: Emerging Applications in the Medical Display Market
https://www.marketsandmarkets.com/Market-Reports/medical-display-market-74058413.html
The global Medical Display Market is projected to reach USD 2.9 billion by 2028 from USD 2.3 billion in 2023, at a CAGR of 5.2% during the forecast period. There are several factors which drive the medical display market like rising technological advancements, increasing demand for diagnostic imaging, rising awareness and adoption of minimally invasive procedures and surge in telemedicine and remote diagnostics.
The market for Medical Display is dominated by companies like Barco NV (Belgium), Eizo (Japan), Sony Electronics Inc. (Japan), Lg Electronics (South Korea), Novanta (US), FSN Medical Technologies (South Korea), Advantech (Taiwan), Quest International (US), Steris (UK), Jusha Medical (China), Siemens Healthineers Ag (Germany), Double Black Imaging (US), HP Development Co. Ltd (US), Stryker (US), and Coje Display (South Korea)Expanding Horizons: Emerging Applications in the Medical Display Market https://www.marketsandmarkets.com/Market-Reports/medical-display-market-74058413.html The global Medical Display Market is projected to reach USD 2.9 billion by 2028 from USD 2.3 billion in 2023, at a CAGR of 5.2% during the forecast period. There are several factors which drive the medical display market like rising technological advancements, increasing demand for diagnostic imaging, rising awareness and adoption of minimally invasive procedures and surge in telemedicine and remote diagnostics. The market for Medical Display is dominated by companies like Barco NV (Belgium), Eizo (Japan), Sony Electronics Inc. (Japan), Lg Electronics (South Korea), Novanta (US), FSN Medical Technologies (South Korea), Advantech (Taiwan), Quest International (US), Steris (UK), Jusha Medical (China), Siemens Healthineers Ag (Germany), Double Black Imaging (US), HP Development Co. Ltd (US), Stryker (US), and Coje Display (South Korea)WWW.MARKETSANDMARKETS.COMMedical Display Market Size, Share, Trends and Revenue Forecast [Latest]The global medical display market in terms of revenue was estimated to be worth $2.3 billion in 2023 and is poised to reach $2.9 billion by 2028, growing at a CAGR of 5.2% from 2023 to 2028.0 Comentários 0 Compartilhamentos - Driving Forces and Growth Prospects in Multiplex Assays
https://www.marketsandmarkets.com/Market-Reports/multiplex-assays-market-61593314.html
The multiplex assays market is valued at an estimated USD 3.5 billion in 2022 and is projected to reach USD 5.3 billion by 2027, at a CAGR of 8.8% during the forecast period. Growth in this market is mainly driven by factors such as increasing use of multiplex assays in companion diagnostics and increasing advantages over singleplex and traditional assays. However, the high cost of multiplex assay equipment, stringent regulations and standards, and issues in the standardization of multiplex assays design are the major factors restraining the growth of this market.
The key players in multiplex assays market are Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), Becton, Dickinson and Company (US), DiaSorin S.p.A. (Italy), QIAGEN N.V. (Netherlands), Abcam plc (UK), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Quanterix (US), Bio-Techne (US), MESO SCALE DIAGNOSTICS, LLC (US), Randox Laboratories Ltd. (UK), Olink (Sweden), Seegene Inc. (South Korea), Siemens Healthcare AG (Germany), PerkinElmer Inc. (US), Shimadzu Corporation (Japan), Promega Corporation (US), Enzo Biochem Inc. (US), Cayman Chemical (US), Boster Biological Technology (US), Antigenix America, Inc. (US), Quansys Biosciences Inc. (US), and RayBiotech Life, Inc. (US).Driving Forces and Growth Prospects in Multiplex Assays https://www.marketsandmarkets.com/Market-Reports/multiplex-assays-market-61593314.html The multiplex assays market is valued at an estimated USD 3.5 billion in 2022 and is projected to reach USD 5.3 billion by 2027, at a CAGR of 8.8% during the forecast period. Growth in this market is mainly driven by factors such as increasing use of multiplex assays in companion diagnostics and increasing advantages over singleplex and traditional assays. However, the high cost of multiplex assay equipment, stringent regulations and standards, and issues in the standardization of multiplex assays design are the major factors restraining the growth of this market. The key players in multiplex assays market are Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), Becton, Dickinson and Company (US), DiaSorin S.p.A. (Italy), QIAGEN N.V. (Netherlands), Abcam plc (UK), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Quanterix (US), Bio-Techne (US), MESO SCALE DIAGNOSTICS, LLC (US), Randox Laboratories Ltd. (UK), Olink (Sweden), Seegene Inc. (South Korea), Siemens Healthcare AG (Germany), PerkinElmer Inc. (US), Shimadzu Corporation (Japan), Promega Corporation (US), Enzo Biochem Inc. (US), Cayman Chemical (US), Boster Biological Technology (US), Antigenix America, Inc. (US), Quansys Biosciences Inc. (US), and RayBiotech Life, Inc. (US).WWW.MARKETSANDMARKETS.COMMultiplex Assays Market Size, Share, Trends, Forecasts Report, Growth Drivers | MarketsandMarketsThe global multiplex assays market in terms of revenue was estimated to be worth $3.5 billion in 2022 and is poised to reach $5.3 billion by 2027, growing at a CAGR of 8.8% from 2022 to 2027.0 Comentários 0 Compartilhamentos - Regulatory Landscape Analysis and Its Impact on the Veterinary API Market
https://www.marketsandmarkets.com/Market-Reports/veterinary-api-market-91801752.html
The Global Veterinary API Market is projected to reach USD 11.9 billion by 2028 from USD 8.5 billion in 2023, at a CAGR of 6.9% the forecast period. There are several factors which drive the Veterinary API Market like rising incidence of transboundary & zoonotic diseases, increasing animal population and pet ownership, and increasing disease control & disease prevention measures. The veterinary API industry is anticipated to develop because of the rising demand for veterinary medicines and other animal health products.
The market for Veterinary API Market is dominated by companies like Phibro Animal Health Corporation (US), Fabbrica Italiana Sintetici S.p.A. (Italy), Sequent Scientific Ltd. (India), Excel Industries Ltd. (India), NGL Fine-Chem Ltd. (India), Insud Pharma (Spain), Menadiona Sl (Spain), Rochem International Inc. (US), and Shaanxi Hanjiang Pharmaceutical Group Co. Ltd. (China)Regulatory Landscape Analysis and Its Impact on the Veterinary API Market https://www.marketsandmarkets.com/Market-Reports/veterinary-api-market-91801752.html The Global Veterinary API Market is projected to reach USD 11.9 billion by 2028 from USD 8.5 billion in 2023, at a CAGR of 6.9% the forecast period. There are several factors which drive the Veterinary API Market like rising incidence of transboundary & zoonotic diseases, increasing animal population and pet ownership, and increasing disease control & disease prevention measures. The veterinary API industry is anticipated to develop because of the rising demand for veterinary medicines and other animal health products. The market for Veterinary API Market is dominated by companies like Phibro Animal Health Corporation (US), Fabbrica Italiana Sintetici S.p.A. (Italy), Sequent Scientific Ltd. (India), Excel Industries Ltd. (India), NGL Fine-Chem Ltd. (India), Insud Pharma (Spain), Menadiona Sl (Spain), Rochem International Inc. (US), and Shaanxi Hanjiang Pharmaceutical Group Co. Ltd. (China)WWW.MARKETSANDMARKETS.COMVeterinary API Market Size, Share, Trends and Revenue Forecast, 2028 | MarketsandMarketsThe global veterinary API market in terms of revenue was estimated to be worth $8.5 billion in 2023 and is poised to reach $11.9 billion by 2028, growing at a CAGR of 6.9% from 2023 to 2028.0 Comentários 0 Compartilhamentos
Mais Stories